Initial Registration of Components - 11/2004
Initial DGQ Gmbh Certification - 10/08/2007
Recertification with DNV - 07/20/2012
Biomorse Implant Line Launch - 09/2013
Biomorse and Biodirect SWE Implant Launch - 03/2018
Recertification with BSI - 11/01/2018
Recertification with BSI - 11/01/2021
Transfer and certification with DNV - 05/22/2024
Recertification with DNV - 10/31/2024
Initial DGQ Gmbh Certification - 10/08/2007
Biodirect Implant Line Launch - 05/2011
Transfer and recertification DNV - 07/10/2012
Recertification with DNV - 10/26/2015
Recertification DNV - 08/13/2018
Inclusion of SWE Implants in CE Marking - 10/23/2020
Legacy products MDD extension letter - 04/07/2023
Biomorse 11.5° Implant Line Launch - 07/2024
To offer high-quality dental implants that provide:
Innovative and efficient solutions for tooth replacement;
Contribution to oral health and patient confidence;
Superior clinical results, with a focus on functionality and aesthetics;
Continuous improvement in the quality of life for those who use our products;
Commitment to safety and efficacy in every procedure.
To be a global reference in dental implants, seeking:
Recognition for innovation, technology, and clinical excellence;
Expansion of Bio Implantes’ presence in national and international markets;
Maintenance of a superior quality standard;
Being the preferred choice of dental professionals;
Leadership in the sector through customer trust and satisfaction.
Bio Implantes was founded in 1993 in Bauru, an important center for dental development in Brazil, known internationally for the presence of USP in the city. Originally called Kunzel Brasil Equipamentos Odontológicos Ltda., the company was created by a group of researchers to bring regenerative solutions to the market, becoming a pioneer in the manufacture of implants. From the beginning, the founders dedicated themselves to research and innovation, being recognized with awards such as the Prêmio Mauá – Sebrae (1988) and the Prêmio Finep de Inovação Tecnológica (2000). However, the company’s growth was hampered by a deficient organizational structure and the absence of profits.
In 2004, the company received an investment from Aurora Ventures, a US venture capital company, through its Brazilian subsidiary, Aurora Health do Brasil Participações Ltda. This investment resulted in a profound restructuring, leading to the creation of Bionnovation Produtos Biomédicos S.A. Over the past 20 years, the company has improved its products and incorporated innovations with excellence, culminating in a spin-off in April 2024, when it assumed the name Bio Health do Brasil LTDA (Bio Implantes).
Today, the company operates in a modern 2,500 m² factory in the interior of São Paulo, dedicated exclusively to the production of dental implants. Located in an industrial district, the unit has state-of-the-art equipment that allows it to achieve the highest quality in its products. Bio Implantes adopts rigorous quality control to meet all legal and good practice requirements, as well as the demands of customers, suppliers, partners and other interested parties, ensuring a commitment to innovation and sustainable growth, led by a highly qualified team.
